• Small Molecules
      • Discovery
        Development
        Manufacturing
    • Large Molecules
      • Discovery
        Development & Manufacturing
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery

      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
    • Emerging Biopharma

      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

        Know More
        Know More
    • Dedicated Centers

      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)

      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
    • Investors
      Corporate Governance
  • Careers

Syngene reports
full year revenue from operations up 19% to INR 2604 Cr (USD 347 Mn)

Revenue from operations up 15% to INR 758 Cr (USD 101 Mn) in fourth quarter

Syngene wins
The CMO Leadership Awards 2022

Across all categories, including Capabilities, Compatibility, Expertise, 
Quality, Reliability, and Service

Transforming research
to sustainable business

We are the partner of choice for over 400+ organizations globally
More
More

Syngene ESG report FY2020-21

In accordance with the Global Reporting Initiative (GRI)

Know More
Know More
Download Report | Watch Video

Who we are

We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

More
More

What we do

We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.

Discovery

Our Discovery Services span the entire spectrum of early stage research from target …

More
More

Development

Our Development Services encompass activities from pre-clinical to clinical trials…

More
More

Manufacturing

Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…

More
More

Dedicated Centers

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…

More
More

InstaVisit - Visit Syngene Virtually

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.

View Now
View Now
Visit Syngene virtually with a 360 degree view of Syngene’s world-class facilities and capabilities
0 +

Clients

0

Collaborations with the top 10 Pharma/Biotech companies

3000 +

Experienced Scientists

0

Mn sq. ft. of R&D and manufacturing infrastructure

0 +

Patents 

Latest news

View all
View all

Syngene reports full year revenue from operations up 19% to Rs. 2604 Cr

More
Press Release
27th Apr, 2022

As startups mushroom in drug R&D, Syngene builds CRO muscle

More
News
16th Mar, 2022

Syngene International takes top honors at CMO Leadership Awards 2022 for contract manufacturing

More
Press Release
9th Mar, 2022

Insights

View all
View all

Driving operational excellence with SQDECC

SQDECC is an industry-recognized model that enables the operational teams to get a unified view of their efficiency across parameters of Safety, Quality, Delivery, Engagement, Cost, and Compliance (SQDECC).
More

How Organocatalysis discovered by Nobel laureates revolutionised drug development and production in Syngene

More

Design of Experiment (DoE) – An efficient tool for process optimization

DoE is achieving increasing acceptance in the pharmaceutical sector as it is being seen as an efficient tool for process optimization, including helping to develop quality products.
More

Upcoming events

View all
View all

Chemspec Europe 2022

31st May & 1st June 2022
Frankfurt
Book Now

Corporate social responsibility

To strive towards developing and sustaining healthy and empowered communities by improving the quality of life.
More
More

Syngene International Ltd

+1.35(0.32%)+1.35(0.32%)

Governance

Behind consistent growth is good governance

More
More

Careers

Discover a world of opportunities

More
More

Annual Reports

Touching a billon lives through innnovation

More
More

Sign-up for our newsletter

© 2022. Syngene International Limited

Twitter Linkedin-in Youtube Facebook-f

Quick Links

Business

Get In Touch

Other Links

Twitter Linkedin-in Youtube Facebook-f

© 2022. Syngene International Limited

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

Close
Close

To download, Please share your details

To download, Please share your details